Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23694901 | 1.00 | CA2 (0.46) | CA2SLC2A1HDAC1HDAC11HDAC8 | |
| SCHEMBL29112979 | 1.00 | CA2 (0.46) | CA2SLC2A1HDAC1HDAC11HDAC8 | |
| SCHEMBL23695648 | 1.00 | CA2 (0.46) | CA2SLC2A1HDAC1HDAC11HDAC8 | |
| SCHEMBL26481429 | 0.98 | CA2 (0.43) | CA2SLC2A1HDAC1HDAC11HDAC8 | |
| SCHEMBL23695275 | 0.93 | CA2 (0.43) | CA2SLC2A1HDAC1HDAC11HDAC8 | |
| SCHEMBL4444118 | 0.85 | ALOX5 (0.42) | ALOX5GLATSHRHTTL3MBTL1 | |
| SCHEMBL25440569 | 0.82 | HDAC1 (0.39) | HDAC1HDAC11HDAC8HDAC6CSNK1E | |
| SCHEMBL20689617 | 0.82 | HDAC1 (0.39) | HDAC1HDAC11HDAC8HDAC6CSNK1E | |
| SCHEMBL5903025 | 0.82 | HDAC1 (0.39) | HDAC1HDAC11HDAC8HDAC6CSNK1E | |
| SCHEMBL14288464 | 0.82 | HDAC1 (0.39) | HDAC1HDAC11HDAC8HDAC6CSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230135729-A1 | COMPOUND WITH ANTI-SPORE ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF | CHENGDU BIOBEL COMPANY LIMITED (CN) | 2023-05-04 | — | — | US | disclosed |
| US-20230135729-A1 | COMPOUND WITH ANTI-SPORE ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF | CHENGDU BIOBEL COMPANY LIMITED (CN) | 2023-05-04 | — | — | US | disclosed |
| WO-2021147123-A1 | COMPOUND HAVING ANTISPORULANT ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF | 成都贝诺科成生物科技有限公司 | 2021-07-29 | — | — | WO | disclosed |
| US-6166003-A | Heterocyclic compounds for cancer chemoprevention | LKT LABORATORIES, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| WO-2000049013-A1 | ISOTHIO CYANATO ALKYLTHIOPHENES AS CANCER CHEMOPROTECTIVE AGENTS | LKT LABORATORIES, INC. (US) | 2000-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230135729-A1 | COMPOUND WITH ANTI-SPORE ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF | CASP9, CLPP, CASP1 | CA2 573/4885SLC2A1 4745/4885HDAC1 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.